SIGNiX Independent E-Signatures™ Featured in Applied Clinical Trials 

The need for speed in clinical trials is astounding. 

A report by Ronald D. Snee of Tunnell Consulting found each day a blockbuster drug is delayed in getting to market, the company forgoes more than $2.7 million in lost or deferred revenue. 

So when Independent E-signatures™ present the opportunity to reduce the time it takes to obtain signatures by days, and often weeks, it’s hard to ignore.

Applied Clinical Trials recently published an article written by our Executive Vice President Pem Guerry, which explains how Independent E-signatures™ can drastically improve clinical trial efficiency, evidenced by one of our “real-world” success stories.

“[Sarah Cannon Research Institute]’s e-signature program was designed to expedite gathering physician signatures on clinical trial documents, encompassing a network of more than 1,000 investigators dispersed globally. This e-signature ability saved SCRI $250,000 in printing and delivery costs in the first year, but even more important, it saved time. Previously, it took between 19 and 58 days to get a document signed. With e-signatures, it took just three to four days – a 94% improvement,” Pem said in the article.

The piece also explains why not just any e-signature is equipped to operate amid the life science industry’s heightened compliance and security needs.

“Because the legal evidence is embedded into a PDF and not reliant on a vendor’s proprietary technology and permanent storage of the document, independent e-signature technologies can be validated, even without an Internet connection, and can live exclusively on a user’s server – not a vendor’s - for greater control,” explained Pem.

This only scratches the surface of the material published. If you’d like to read the entire article, you can download the free PDF by clicking below: